Document ID: chunk:federal_register_of_legislation:F2025L00213:clause:1_20
Version: federal_register_of_legislation:F2025L00213
Segment Type: clause
Provision Reference: sch 1 cl 20
Character Range: 11243–13024

20  Schedule 1 (table)
Omit:
Perindopril                  Tablet containing perindopril erbumine 2 mg                                      Oral  Indosyl Mono 2        (a) between 1 July 2023 and 31 December 2023—4 months stock by reference to usual demand
                                                                                                                                          (b) after 31 December 2023—5 months stock by reference to usual demand
Perindopril                  Tablet containing perindopril erbumine 4 mg                                      Oral  Indosyl Mono 4        (a) between 1 July 2023 and 31 December 2023—4.5 months stock by reference to usual demand
                                                                                                                                          (b) after 31 December 2023—5.5 months stock by reference to usual demand
Perindopril with indapamide  Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg  Oral  Indosyl Combi 4/1.25  (a) between 1 July 2023 and 31 December 2023—4 months stock by reference to usual demand
                                                                                                                                          (b) after 31 December 2023—5 months stock by reference to usual demand
Perindopril with indapamide  Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg  Oral  Perindo Combi 4/1.25  (a) between 1 July 2023 and 31 December 2023—2 months stock by reference to usual demand
                                                                                                                                          (b) after 31 December 2023—2.5 months stock by reference to usual demand